期刊文献+

活检术前应用皮质醇对原发性中枢神经系统淋巴瘤病理诊断的影响 被引量:6

Effect of corticosteroid administration before biopsy on histopathological diagnosis of primary central nervous system lymphoma
下载PDF
导出
摘要 目的研究活检术前应用皮质醇是否会影响原发性中枢神经系统淋巴瘤的病理诊断。方法回顾分析2005年2月至2011年2月期间73例经立体定向活检诊断为原发性中枢神经系统淋巴瘤患者的资料。结果 73例淋巴瘤患者中,39例(53.4%)在活检术前应用皮质醇;10例(73;13.7%)未得出阳性结果,再次行立体定向活检或开颅被证实为原发性中枢神经系统淋巴瘤,其中5例(39例)术前应用过皮质醇(12.8%),5例(34例)未使用皮质醇(14.7%)(P=1.0)。结论活检术前应用皮质醇对大部分原发性中枢神经系统淋巴瘤患者而言不影响其病理诊断。 Objective To determine whether corticosteroid administration before biopsy prevents histopathological diagnosis of primary central nervous system lymphoma(PCNSL).Methods A retrospective review was performed of 73 PCNSL patients identified by stereotactic biopsy from Feb 2005 to Feb 2011.Results A total of 73 patients was identified.Thirty-nine patients(53.4%)received corticosteroids before diagnosis.Ten patients(of 73;13.7%) had undergone repeat stereotactic biopsy or craniotomy to confirm PCNSL.These include 5(of 39) patients who had received corticosteroids(12.8%),and 5(of 34) who had not(14.7%)(P=1.0).Conclusion ns The majority of PCNSL patients who received corticosteroids before diagnosis did not require second biopsy for diagnosis.
出处 《中国实验诊断学》 北大核心 2011年第5期828-829,共2页 Chinese Journal of Laboratory Diagnosis
关键词 原发性中枢神经系统淋巴瘤 皮质醇 活检术 病理诊断 影响 primary central nervous system lymphoma corticosteroid Stereotactic biopsy histopathological diagnosis effect
  • 相关文献

参考文献6

  • 1Olson JE,Janney CA,Rao RD,et al.The continuing increase the incidence of primary central nervous system non-Hodgkin lymphoma:A surveillanc e,epidemiology,and end results analysis[J].Cancer,2002,95(7):1504.
  • 2Gündüz K,Pulido JS,McCannel CA,et al.Ocular manifestations and treatment of primary central nervous system lymphoma[J].Neurosurg Focus,2006,21(5):E9.
  • 3Küker W,Ngele T,Korfel A,et al.Primary central nervous system lymphomas(PCNSL):MRI features at presentation in 100 patients[J].J Neurooncol,2005,72(2):169.
  • 4余剑,陈向燕,范玉华,赵湛,崔春梅,黄如训,曾进胜.免疫功能正常的原发性中枢神经系统淋巴瘤22例临床病理分析[J].中国神经精神疾病杂志,2004,30(1):27-29. 被引量:5
  • 5Elizabeth R,Gerstner et al.Primary central nervous system lymphoma[J].J Arch Neurol,2010,67(3):291.
  • 6Porter AB,Giannini C,Kaufmann T,et al.Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use:A pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma[J].Annals of Neurology,2008,63(5):662.

二级参考文献12

  • 1[1]Nasir S, DeAngelis LM. Update on the management of primary CNS lymphonuc. Oncology(Huntingt), 2000, 14(2): 228.
  • 2[2]National Cancer Institute. The non-Hodgkin's lymphoma pathologic classification project: NCI sponsored study of classification of non-Hodgkin's lymphoma: summary and description of a working formulation for clinical usage. Cancer, 1982, 49(10): 2112.
  • 3[3]Plasswilm L, Herrlinger U, Korfel A, et al. Primary central nervous system (CNS) lymphoma in irnmunocompetent patients. Ann Hematol,2002, 81(8):415.
  • 4[4]McAllister LD. Primary central nervous system lymphoma: a review. Curr Neurol Neurosci Rep, 2002, 2(3): 210.
  • 5[5]Basso U, Brandes AA. Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma. Eur J Cancer, 2002,38(10): 1298.
  • 6[6]Herrlinger U, Schabet M, Bitzer M, et al. Primary central nervous system lymphoma: from clinical presentation to diagnosis. J Neurooneol,1999, 43(3) :219.
  • 7[7]Herrlinger U. Primary CNS lymphoma: findings outside the brain. J Neurooncol, 1999, 43(3): 227.
  • 8[8]DeAngelis LM. Primary central nervous system lymphoma [ editorial]. J Neurol Neurosurg Psychiatry, 1999, 66(6): 699.
  • 9[9]Schabet M. Epidemiology of primary CNS lymphoma. J Neurooncol,1999,43(3): 199.
  • 10[10]Buhring U, Herrlinger U, Kfings T, et al. MRI features of primary central nervous system lymphomas at presentation. Neurology, 2001, 57(3): 393.

共引文献4

同被引文献68

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部